Protalix BioTherapeutics Inc (PLX) Actualités

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form 8-K - Current report

Form 424B3 - Prospectus [Rule 424(b)(3)]

Current Report Filing (8-k)

0001006281false00010062812023-06-282023-06-28​​UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C...

Form 8-K - Current report

Additional Proxy Soliciting Materials (definitive) (defa14a)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 14A   Proxy...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Current Report Filing (8-k)

0001006281false00010062812023-05-302023-05-30​​UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C...

Proxy Statement (definitive) (def 14a)

​ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

Current Report Filing (8-k)

0001006281false00010062812023-05-182023-05-18​​UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C...